Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126961912 | 12696191 | 2 | F | 20160908 | 20160829 | 20160912 | EXP | MY-FRI-1000086877 | FOREST | DEENA F,BIN SIDI H,THAMBU M. WHEN ELECTROCONVULSIVE THERAPY FAILS: COGNITIVE-BEHAVIORAL THERAPY IN TREATMENT-RESISTANT BIPOLAR DEPRESSION. A CASE REPORT. ARCHIVES OF PSYCHIATRY AND PSYCHOTHERAPY. 2016;67-69. | 45.00 | YR | M | Y | 0.00000 | 20160912 | OT | MY | MY |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126961912 | 12696191 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG | Y | 20822 | 20 | MG | QD | ||||||
| 126961912 | 12696191 | 2 | SS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Unknown | 20 MG | Y | 21323 | 20 | MG | QD | ||||||
| 126961912 | 12696191 | 3 | C | hypoglycemic agent | 2 | Oral | 0 | ||||||||||||
| 126961912 | 12696191 | 4 | C | SODIUM VALPROATE | VALPROATE SODIUM | 1 | Unknown | 0 | |||||||||||
| 126961912 | 12696191 | 5 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 0 | |||||||||||
| 126961912 | 12696191 | 6 | C | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 0 | |||||||||||
| 126961912 | 12696191 | 7 | C | QUETIAPINE XR | QUETIAPINE | 1 | Unknown | UPTITRATED TO 400 MG DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126961912 | 12696191 | 1 | Depressive symptom |
| 126961912 | 12696191 | 2 | Product used for unknown indication |
| 126961912 | 12696191 | 3 | Product used for unknown indication |
| 126961912 | 12696191 | 4 | Product used for unknown indication |
| 126961912 | 12696191 | 5 | Product used for unknown indication |
| 126961912 | 12696191 | 6 | Product used for unknown indication |
| 126961912 | 12696191 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126961912 | 12696191 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126961912 | 12696191 | Bipolar I disorder | |
| 126961912 | 12696191 | Drug ineffective | |
| 126961912 | 12696191 | Sexual dysfunction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |